» Articles » PMID: 36013052

Expression of ABCA1 Transporter and LXRA/LXRB Receptors in Placenta of Women with Late Onset Preeclampsia

Abstract

Background: Appropriate levels of cholesterol are necessary for the mother and developing fetus, but theirexcess may cause preeclampsia. The ABCA1 transporter mediates the secretion of cholesterol and is highly regulated at the transcriptional level via the nuclear liver X receptors (LXRs).

Methods: Sixteen preeclamptic and 39 normotensives healthy women with uncomplicated pregnancies were involved in the case-control study. The placental levels of ABCA1, LXRA and LXRB mRNA were quantified by real-time quantitative PCR. The concentrations of ABCA1, LXRA and LXRB proteins from the placenta were determined using an enzyme-linked immunosorbent assay Results: We found in the logistic regression model significantly lower placental expression of LXRB mRNA (crude OR = 0.26, 95% CI: 0.07-0.94, = 0.040) and LXRA protein level (crude OR = 0.19, 95% CI: 0.05-0.69, = 0.012) in late-onset preeclamptic women compared to healthy pregnant women. The values remained statistically significant after adjustment for possible confounders.

Conclusions: Our results suggest that high placenta LXRA mRNA and LXRA protein expression levels decrease the risk of late-onset preeclampsia. These nuclear receptors could play a role in the development of preeclampsia through disturbances of lipid metabolism.

Citing Articles

Pregnancy Metabolic Adaptation and Changes in Placental Metabolism in Preeclampsia.

Li Y, Ma L, He R, Teng F, Qin X, Liang X Geburtshilfe Frauenheilkd. 2024; 84(11):1033-1042.

PMID: 39524034 PMC: 11543110. DOI: 10.1055/a-2403-4855.

References
1.
Vousden N, Lawley E, Seed P, Gidiri M, Goudar S, Sandall J . Incidence of eclampsia and related complications across 10 low- and middle-resource geographical regions: Secondary analysis of a cluster randomised controlled trial. PLoS Med. 2019; 16(3):e1002775. PMC: 6440614. DOI: 10.1371/journal.pmed.1002775. View

2.
Charkiewicz K, Goscik J, Blachnio-Zabielska A, Raba G, Sakowicz A, Kalinka J . Sphingolipids as a new factor in the pathomechanism of preeclampsia - Mass spectrometry analysis. PLoS One. 2017; 12(5):e0177601. PMC: 5438119. DOI: 10.1371/journal.pone.0177601. View

3.
Spracklen C, Smith C, Saftlas A, Robinson J, Ryckman K . Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis. Am J Epidemiol. 2014; 180(4):346-58. PMC: 4565654. DOI: 10.1093/aje/kwu145. View

4.
Mutemberezi V, Buisseret B, Masquelier J, Guillemot-Legris O, Alhouayek M, Muccioli G . Oxysterol levels and metabolism in the course of neuroinflammation: insights from in vitro and in vivo models. J Neuroinflammation. 2018; 15(1):74. PMC: 5845224. DOI: 10.1186/s12974-018-1114-8. View

5.
Abalos E, Cuesta C, Grosso A, Chou D, Say L . Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013; 170(1):1-7. DOI: 10.1016/j.ejogrb.2013.05.005. View